Nov 10 (Reuters) - PAION AG PA8G.DE :
* PAION AG PUBLISHES GROUP QUARTERLY STATEMENT FOR
THE
FIRST NINE MONTHS OF 2021
* 9M REVENUE 5.5 MILLION EUR
* TRANSFORMATION INTO COMMERCIAL SPECIALTY PHARMA COMPANY
FOLLOWING EXPANSION OF EUROPEAN PRODUCT PORTFOLIO; ANGIOTENSIN
II SUCCESSFULLY LAUNCHED IN Q3 2021
* FINANCIAL POSITION STRENGTHENED TO SUPPORT PRODUCT
LAUNCHES: EUR
7.8 MILLION GROSS PROCEEDS RAISED IN RIGHTS ISSUE AND EUR 20
MILLION LOAN FULLY DRAWN FROM EIB
Source text for Eikon: ID:nEQ1pSKTha
Further company coverage: PA8G.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))